Xalud Therapeutics, Inc.
8 clinical trials · Sponsor
◉ Watch Xalud Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety Study of XT-150 in Participants With ALS (NCT06704347) | Xalud Therapeutics, Inc. | 2027-03-01 |
| Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain (NCT05196919) | Xalud Therapeutics, Inc. | 2022-02-24 |
| Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis (NCT04841512) | Xalud Therapeutics, Inc. | 2021-10-01 |
| Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain (NCT04466410) | Xalud Therapeutics, Inc. | 2021-04-14 |
| Efficacy and Safety of XT-150 in Osteoarthritis of the Knee (NCT04124042) | Xalud Therapeutics, Inc. | 2020-02-14 |
| Follow on Extension of XT-150-1-0201 (NCT03769662) | Xalud Therapeutics, Inc. | 2019-03-20 |
| Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain (NCT03282149) | Xalud Therapeutics, Inc. | 2018-03-21 |
Track Xalud Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.